Concentra Group Holdings Parent downgraded by BofA Securities with a new price target
$CON
Medical Specialities
Health Care
BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously